STOCKSCREENR
Log In

NUTX

NASDAQ

Nutex Health, Inc.

$94.01+1.31(+1.41%)Mkt Cap: $559.77M

Key Stats

Market Cap

$559.77M

P/E Ratio

8.97

EPS

$10.48

Dividend Yield

0.00%

52-Week Range

$45.88 — $193.07

Volume

123.19K

Avg Volume

194.42K

Beta

2.00

Valuation

P/E (TTM)

8.97

Forward P/E

4.48

PEG Ratio

0.06

P/S (TTM)

0.66

P/B (TTM)

2.29

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.46%

ROA (TTM)

0.12%

ROIC

—

Gross Margin

0.55%

Operating Margin

0.36%

Net Margin

—

Debt/Equity

1.23

Current Ratio

3.20

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.37%

EPS Growth (5Y)

+0.89%

Sales Growth (3Y)

+0.24%

Sales Growth (5Y)

+0.55%

EPS Est (This Year)

$21.00

EPS Est (Next Year)

$25.94

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$24.78

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

5.95M

Float

2.94M

Free Float %

49.44%

About

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

NASDAQ

IPO Date

2022-04-04

Employees

800

CEO

Thomas T. Vo

Index Membership

—

Website

https://www.nutexhealth.com

Nutex Health, Inc. (NUTX) is a healthcare company in the medical - healthcare information services industry listed on the NASDAQ. With a market capitalization of $559.77M, a P/E ratio of 8.97, NUTX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NUTX against other stocks using dozens of fundamental and technical filters.

Similar Stocks

CTEV

Claritev Corporation

$16.92

-3.86%

$280.07M

SOPH

SOPHiA GENETICS S.A.

$5.00

+1.83%

$358.34M

SDGR

Schrödinger, Inc.

$12.29

-3.23%

$907.31M

CARL

CARLSMED, INC.

$11.70

+0.00%

$312.76M

HTFL

Heartflow, Inc. Common Stock

$22.52

+7.34%

$1.92B

WGS

GeneDx Holdings Corp.

$75.50

-0.80%

$2.21B

Frequently Asked Questions

What is Nutex Health, Inc.'s P/E ratio?

Nutex Health, Inc. (NUTX) has a trailing twelve-month (TTM) P/E ratio of 8.97. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Nutex Health, Inc. pay a dividend?

No, Nutex Health, Inc. (NUTX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Nutex Health, Inc.'s market cap?

Nutex Health, Inc. (NUTX) has a market capitalization of $559.77 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.